SBFM
Sunshine Biopharma
$1.53
−$0.13 (−7.83%)Jul 27, 2026
Key metrics
The numbers that frame SBFM today
- Market cap
- $765.91K
- P/E (TTM)
- -0.1
- EV / FCF
- 0.9
- Gross margin
- 33%
- EV / Sales
- -0.2
- ROIC
- -42.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.44
- 52wk High
- $24.30
Growth
Revenue and earnings trend for SBFM
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SBFM
Is Sunshine Biopharma a good buy?
No. Sunshine Biopharma has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of SBFM?
Sunshine Biopharma's market capitalization is $765.91K.
What is the P/E ratio for SBFM stock?
Sunshine Biopharma's current P/E ratio is -0.1.
What is the 52-week high for SBFM stock?
The 52-week high for Sunshine Biopharma is $24.30. The current close of $1.53 is 93.7% below that high.
What is the 52-week low for SBFM stock?
The 52-week low for Sunshine Biopharma is $1.44. The current close of $1.53 is 6.3% above that low.
Does SBFM stock pay dividends?
Sunshine Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SBFM?
Sunshine Biopharma's Debt / Equity ratio is 0.04.